Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy
Crossref DOI link: https://doi.org/10.1186/s12931-016-0433-5
Published Online: 2016-09-23
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Halpin, David M. G.
Kerkhof, Marjan
Soriano, Joan B.
Mikkelsen, Helga
Price, David B.
Funding for this research was provided by:
Boehringer Ingelheim
